receptor, cannabinoid, CB1

Preferred Label : receptor, cannabinoid, CB1;

MeSH definition : A subclass of cannabinoid receptor found primarily on central and peripheral NEURONS where it may play a role modulating NEUROTRANSMITTER release.;

MeSH synonym : cb1 receptor; receptor, cb1; cannabinoid receptor cb1; receptor cb1, cannabinoid;

Wikipedia link : https://en.wikipedia.org/wiki/Receptor, cannabinoid, cb1;

Is substance : O;

Details

Origin ID

D043884;

UMLS CUI

C0378126;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- physiology [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Cannabinoid receptor 1 [OMIM gene]
Indexing information
- (-)-adamantyl-delta8-tetrahydrocannabinol [MeSH Supplementary Concept]
- (2-(2,4-dichlorophenyl)-6-fluoro-2-(4-fluorophenyl)benzo(1,3)dioxol-5-yl)morpholin-4-ylmethanone [MeSH Supplementary Concept]
- (5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)(piperidin-1-yl)methanone [MeSH Supplementary Concept]
- 1,3-bis(4-bromophenyl)-5-phenylimidazolidine-2,4-dione [MeSH Supplementary Concept]
- 1,3-dihydroxypropan-2-yl 11-(2-hexyl-5-hydroxyphenoxy)undecanoate [MeSH Supplementary Concept]
- 1,3-dihydroxypropan-2-yl 11-(3-hydroxy-5-(2-methyloctan-2-yl)phenoxy)undecanoate [MeSH Supplementary Concept]
- 1-(1-pentyl-1H-indol-3-yl)-2-o-tolylethanone [MeSH Supplementary Concept]
- 1-(2,4-dichlorophenyl)-4-ethyl-5-(5-(2-(4-(trifluoromethyl)phenyl)ethynyl)thiophen-2-yl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide [MeSH Supplementary Concept]
- 1-(2,4-dichlorophenyl)-4-ethyl-5-(5-(2-phenylethynyl)thiophen-2-yl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide [MeSH Supplementary Concept]
- 1-(2,4-dichlorophenyl)-N-(piperidin-1-yl)-4-((pyrrolidine-1-sulfonamido)methyl)-5-(5-((4-(trifluoromethyl)phenyl)ethynyl)thiophene-2-yl)-1H-pyrazole-3-carboxamide [MeSH Supplementary Concept]
- 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-5-methyl-N-(piperidin-1-yl)-1H-imidazole-4-carboxamide [MeSH Supplementary Concept]
- 1-(4-chlorophenyl)-3-(3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl)urea [MeSH Supplementary Concept]
- 1-(7-(2-chlorophenyl)-8-(4-chlorophenyl)-2-methylpyrazolo(1,5-a)(1,3,5)triazin-4-yl)-3-(methylamino)azetidine-3-carboxamide [MeSH Supplementary Concept]
- 1-(9-(4-chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-yl)-4-ethylaminopiperidine-4-carboxylic acid amide [MeSH Supplementary Concept]
- 1-pentyl-3-(1-naphthoyl)indole [MeSH Supplementary Concept]
- 11-(3-chloro-4-fluorophenyl)dibenzo(b,f)(1,4)thiazepine-8-carboxylic acid butylamide [MeSH Supplementary Concept]
- 18-(5-methyl-2,5-diazabicyclo(2.2.1)heptan-2-yl)-18-oxooctadec-9-en-7-yl phenylacetate [MeSH Supplementary Concept]
- 2-(1-(2-chlorophenyl)-5-(4-chlorophenyl)-4-(methylsulfonyl)-1H-pyrazol-3-yl)-5-(1-(trifluoromethyl)cyclobutyl)-1,3,4-thiadiazole [MeSH Supplementary Concept]
- 2-(2-chlorophenyl)-3-(4-chlorophenyl)-7-(2,2-difluoropropyl)-6,7-dihydro-2H-pyrazolo(3,4-f)(1,4)oxazepin-8(5H)-one [MeSH Supplementary Concept]
- 2-(5-(4-bromophenyl)-1-(2-chlorophenyl)-4-(methylsulfonyl)-1H-pyrazol-3-yl)-5-(1-(trifluoromethyl)cyclobutyl)-1,3,4-thiadiazole [MeSH Supplementary Concept]
- 3-(1-(1-((4-chlorophenyl)(3-(5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)phenyl)methyl)azetidin-3-yl)-2-fluoro-2-methylpropyl)-5-fluorobenzonitrile [MeSH Supplementary Concept]
- 3-(1-hexylcyclobut-1-yl)-6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo(b,d)pyran-1,9 diol [MeSH Supplementary Concept]
- 3-(4-chlorophenyl)-N-methyl-N'-((4-chlorophenyl)sulfonyl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamidine [MeSH Supplementary Concept]
- 4-cyano-1-(2-iodophenyl)-5-(4-methoxyphenyl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide [MeSH Supplementary Concept]
- 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(pyridin-3-methyl)-1H-pyrazole-3-carboxamide [MeSH Supplementary Concept]
- 5-chloro-3-ethyl-1-methyl-N-(4-(piperidin-1-yl)phenethyl)-1H-indole-2-carboxamide [MeSH Supplementary Concept]
- 5-chloro-3-ethyl-1H-indole-2-carboxylic acid (2-(4-piperidin-1-yl-phenyl)ethyl)amide [MeSH Supplementary Concept]
- 5-chloro-3-pentyl-N-(4-(piperidin-1-yl)phenethyl)-1H-indole-2-carboxamide [MeSH Supplementary Concept]
- 8-(5-(2-Methyloctan-2-yl)phenoxy)octanoic acid cyclopropylamide [MeSH Supplementary Concept]
- 9-(hydroxymethyl)-3-(1-adamantyl)hexahydrocannabinol [MeSH Supplementary Concept]
- AM 6527 [MeSH Supplementary Concept]
- AM6545 [MeSH Supplementary Concept]
- LY2190416 [MeSH Supplementary Concept]
- N,N'-(iminodiheptane-7,1-diyl)bis(5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide) [MeSH Supplementary Concept]
- N-(1-(8-(2-chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl)-4-phenylpiperidin-4-yl)methanesulfonamide [MeSH Supplementary Concept]
- N-(1-(cyclohexylmethyl)-2-((5-ethoxypyridin-2-yl)methyl)-1H-benzo(d)imidazol-5-yl)-N-methylthiophene-2-sulfonamide [MeSH Supplementary Concept]
- N-(3-((3-aminopropyl)amino)propyl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide [MeSH Supplementary Concept]
- N-(3-chlorobenzyl)-3-(5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)acrylamide [MeSH Supplementary Concept]
- N-(6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano(2,3-b)pyridin-4-yl)-5-methyl-1H-pyrazole-3-carboxamide [MeSH Supplementary Concept]
- N-(7-(1-hydroxyethyl)-3-(4-isopropylphenyl)-4,6-dimethyl-2,3-dihydro-1-benzofuran-5-yl)-3,3-dimethylbutanamide [MeSH Supplementary Concept]
- N-cyclohexyl-4-(1-(2,4-dichlorophenyl)-1-(p-tolyl)methyl)piperazine-1-carboxamide [MeSH Supplementary Concept]
- N-piperidinyl-7-bromo-1-(2',4'-dichlorophenyl)-4,5-dihydro-1H-thieno(2,3-g) indazol-3-carboxamide [MeSH Supplementary Concept]
- O 1812 [MeSH Supplementary Concept]
- SLV 330 [MeSH Supplementary Concept]
- naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone [MeSH Supplementary Concept]
- sesquicannabigerol [MeSH Supplementary Concept]
Record concept(s)
- receptor, cannabinoid, CB1 [MeSH concept]
Related MeSH Supplementary Concept(s)
- CNR1 protein, human [MeSH Supplementary Concept]
- CNR1 protein, mouse [MeSH Supplementary Concept]
- Cnr1 protein, rat [MeSH Supplementary Concept]
- Cnr1 protein, zebrafish [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Receptor [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients